Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase I/II study of SB-FIX for the treatment of haemophilia B.

Trial Profile

A phase I/II study of SB-FIX for the treatment of haemophilia B.

Status: Planning
Phase of Trial: Phase I/II

Latest Information Update: 06 Mar 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs SB FIX (Primary)
  • Indications Haemophilia B
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Mar 2017 New trial record
    • 11 Jan 2017 According to the Sangamo Therapeutics media release, company plans to initiate the trial in 2017 and data is expected in late 2017 or early 2018.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top